Uncategorized
FDA Issues Warning Letters Alleging Unapproved New Drug Status and CGMP Non-Compliance
By Alvin J. Lorman, AAHP Counsel The Food and Drug Administration (FDA) has issued two Warning Letters that should be of intertest to all manufacturers and distributors of homeopathic drugs. …
Read MoreQuality by Design
By Mark Land, M.S., RAC-US, AAHP Quality by Design (QbD) is a systematic approach to product and process development that begins with predefined objectives and emphasizes product and process understanding…
Read MoreSupplier Audits
The Federal Trade Commission recently published rules regarding consumer endorsements and testimonials which take effect in less than two months. The rules are wide ranging and cover: relationships , compensation, prohibitions, misrepresentation or far more. Violators will be fined under the new rules. The AAHP has prepared a brief overview of …
Read More10 Q&A on Homeopathy
Complied here is a brief fact sheet that AAHP uses when introducing homeopathy to Congressional health staff on Capitol Hill. More robust information can be found on TheAAHP.org’s frequently asked…
Read MoreHelpful Tips to Answer Common Questions (Fighting Misperceptions)
By Mark Land, M.S., RAC-US, AAHP Answering common questions or “frequently asked questions” (FAQs) is an engagement concept that probably dates back forever. The goal is always to answer once…
Read MoreMaturing of Research in Homeopathy Seen at 2025 HRI Conference
By Mark Land, M.S., RAC-US, AAHP President This June, the Homeopathy Research Institute hosted its 6th international research conference on homeopathy and, for the second time, AAHP sponsored the event.…
Read MoreHighlights of the 2025 Homeopathic Research Institute Conference in Greece
AAHP’s picks from attending and from the HRI Conference Booklet The Homeopathy Research Institute (HRI) held its 6th international research conference on homeopathy in Thessaloniki, Greece, June 20–22, 2025. The…
Read More2024 HRI Evidence Summary: Data-Driven Evidence for Homeopathy
The Homeopathy Research Institute’s latest review of global research paints a clear picture: the evidence base for homeopathy is steadily growing in both size and quality. Fundamental research continues to…
Read MoreHistorical Research of Interest
When one reads current journals, or has an opportunity to write for them, there is an emphasis on “current” research. This usually means material published less than eight years prior…
Read MoreHomeopathic Product Statistics in FDA’s Office of Pharmaceutical Quality Annual Report
For the seventh time, the Office of Pharmaceutical Quality (OPQ) in FDA’s Center for Drug Evaluation and Research (CDER) published its “Fiscal Year 2024 Report on the State of Pharmaceutical Quality.” The…
Read More